Table 2.
Site 1 | Site 2 | Total | |
---|---|---|---|
| |||
Systolic BP Baseline, mmHg | |||
Mean ± SD | 137.62 ± 20.5 | 138.15 ± 16.97 | 137.87 ± 18.8 |
(Range), n | (98, 191) n = 45 | (101, 175) n = 39 | (98, 191) n = 84 |
Systolic BP Month 1, mmHg | |||
Mean ± SD | 135.29 ± 17.09 | 129.65 ± 16.24 | 133.44 ± 16.9 |
(Range), n | (98, 191) n = 41 | (100, 156) n = 20 | (98, 191) n = 61 |
Primary Outcome Month 1 – Baseline, mmHg | |||
Mean Change ± SD | −2.66b ± 19.56 | −8.0 ± 16.9 | −4.41 ± 18.76 |
t = −0.87, p = 0.39 | t = −2.12, p = 0.048 | t = −1.84, p = 0.07 | |
n = 41 | n = 20 | n = 61 | |
Systolic BP Month 3, mmHg | |||
Mean ± SD | 134.48 ± 14.09 | ||
(Range), n | (105, 165), n = 33 | ||
Month 3-Baseline, mmHg | |||
Mean Change ± SD | −3.51 ± 17.2 | ||
t = −1.17, p = 0.25 | |||
n = 33 | |||
Controlleda BP, Baseline | 71.1% | 64.1% | 67.9% |
Controlleda BP, Month 1 | 80.5% (χ2 = 2.67, p = 0.10) | 90% (χ2 = 0.33, p = 0.56) | 83.6% (χ2 = 2.78, p = 0.10) |
Controlleda BP, Month 3 | 81.8% (χ2 = 1.90, p = 0.17) |
As defined by JNC-8 Guidelines (32).
Bold items reflect the primary outcomes and associated measures of their significance.